The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inhaled Generic Drugs Market Research Report 2025
Synopsis
Inhalation preparation is a special dosage form that is administered through the lungs. It can quickly and directly enter the lungs to exert drug effects through local administration, reducing the dosage and improving the efficacy of the drug. This report mainly focuses on inhaled generic drugs market.
The global Inhaled Generic Drugs market was valued at US$ 617 million in 2023 and is anticipated to reach US$ 875.2 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
Inhaled drug delivery has the advantages of fast onset of action, rapid absorption, and few side effects. From the perspective of global mature markets, inhaled drug delivery is the mainstream treatment drug for respiratory diseases and the competitive landscape is relatively stable. There is great clinical demand in the field of inhaled formulations for asthma and COPD. China's market for asthma and inhaled preparations has broad prospects, and the rise of Chinese pharmaceutical companies is expected to come as China's domestic generic varieties are launched one after another.
This report aims to provide a comprehensive presentation of the global market for Inhaled Generic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Generic Drugs.
Report Scope
The Inhaled Generic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhaled Generic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled Generic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
AstraZeneca
Boehringer-Ingelheim
CTTQ
Sphsine
Daphne Pharmaceutical
Jewim Pharmaceutical
CF PharmTech
Xianju Pharmaceutical
Joincare Pharmaceutical
Hengrui Medicine
Purity Pharmaceutical
Segment by Type
DPI
MDI
NEB
Segment by Application
Asthma
COPD
Inhalation Anesthesia
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaled Generic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaled Generic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Inhalation preparation is a special dosage form that is administered through the lungs. It can quickly and directly enter the lungs to exert drug effects through local administration, reducing the dosage and improving the efficacy of the drug. This report mainly focuses on inhaled generic drugs market.
The global Inhaled Generic Drugs market was valued at US$ 617 million in 2023 and is anticipated to reach US$ 875.2 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
Inhaled drug delivery has the advantages of fast onset of action, rapid absorption, and few side effects. From the perspective of global mature markets, inhaled drug delivery is the mainstream treatment drug for respiratory diseases and the competitive landscape is relatively stable. There is great clinical demand in the field of inhaled formulations for asthma and COPD. China's market for asthma and inhaled preparations has broad prospects, and the rise of Chinese pharmaceutical companies is expected to come as China's domestic generic varieties are launched one after another.
This report aims to provide a comprehensive presentation of the global market for Inhaled Generic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Generic Drugs.
Report Scope
The Inhaled Generic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhaled Generic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled Generic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
AstraZeneca
Boehringer-Ingelheim
CTTQ
Sphsine
Daphne Pharmaceutical
Jewim Pharmaceutical
CF PharmTech
Xianju Pharmaceutical
Joincare Pharmaceutical
Hengrui Medicine
Purity Pharmaceutical
Segment by Type
DPI
MDI
NEB
Segment by Application
Asthma
COPD
Inhalation Anesthesia
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaled Generic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaled Generic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Inhaled Generic Drugs Market Overview
1.1 Product Overview and Scope of Inhaled Generic Drugs
1.2 Inhaled Generic Drugs Segment by Type
1.2.1 Global Inhaled Generic Drugs Market Value Comparison by Type (2024-2030)
1.2.2 DPI
1.2.3 MDI
1.2.4 NEB
1.3 Inhaled Generic Drugs Segment by Application
1.3.1 Global Inhaled Generic Drugs Market Value by Application: (2024-2030)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Inhalation Anesthesia
1.3.5 Others
1.4 Global Inhaled Generic Drugs Market Size Estimates and Forecasts
1.4.1 Global Inhaled Generic Drugs Revenue 2019-2030
1.4.2 Global Inhaled Generic Drugs Sales 2019-2030
1.4.3 Global Inhaled Generic Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Inhaled Generic Drugs Market Competition by Manufacturers
2.1 Global Inhaled Generic Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Inhaled Generic Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Inhaled Generic Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Inhaled Generic Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhaled Generic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhaled Generic Drugs, Product Type & Application
2.7 Inhaled Generic Drugs Market Competitive Situation and Trends
2.7.1 Inhaled Generic Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inhaled Generic Drugs Players Market Share by Revenue
2.7.3 Global Inhaled Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhaled Generic Drugs Retrospective Market Scenario by Region
3.1 Global Inhaled Generic Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Inhaled Generic Drugs Global Inhaled Generic Drugs Sales by Region: 2019-2030
3.2.1 Global Inhaled Generic Drugs Sales by Region: 2019-2024
3.2.2 Global Inhaled Generic Drugs Sales by Region: 2025-2030
3.3 Global Inhaled Generic Drugs Global Inhaled Generic Drugs Revenue by Region: 2019-2030
3.3.1 Global Inhaled Generic Drugs Revenue by Region: 2019-2024
3.3.2 Global Inhaled Generic Drugs Revenue by Region: 2025-2030
3.4 North America Inhaled Generic Drugs Market Facts & Figures by Country
3.4.1 North America Inhaled Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Inhaled Generic Drugs Sales by Country (2019-2030)
3.4.3 North America Inhaled Generic Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhaled Generic Drugs Market Facts & Figures by Country
3.5.1 Europe Inhaled Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Inhaled Generic Drugs Sales by Country (2019-2030)
3.5.3 Europe Inhaled Generic Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Inhaled Generic Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Inhaled Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Inhaled Generic Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Inhaled Generic Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Inhaled Generic Drugs Market Facts & Figures by Country
3.7.1 Latin America Inhaled Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Inhaled Generic Drugs Sales by Country (2019-2030)
3.7.3 Latin America Inhaled Generic Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Inhaled Generic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhaled Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Inhaled Generic Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Inhaled Generic Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhaled Generic Drugs Sales by Type (2019-2030)
4.1.1 Global Inhaled Generic Drugs Sales by Type (2019-2024)
4.1.2 Global Inhaled Generic Drugs Sales by Type (2025-2030)
4.1.3 Global Inhaled Generic Drugs Sales Market Share by Type (2019-2030)
4.2 Global Inhaled Generic Drugs Revenue by Type (2019-2030)
4.2.1 Global Inhaled Generic Drugs Revenue by Type (2019-2024)
4.2.2 Global Inhaled Generic Drugs Revenue by Type (2025-2030)
4.2.3 Global Inhaled Generic Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Inhaled Generic Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Inhaled Generic Drugs Sales by Application (2019-2030)
5.1.1 Global Inhaled Generic Drugs Sales by Application (2019-2024)
5.1.2 Global Inhaled Generic Drugs Sales by Application (2025-2030)
5.1.3 Global Inhaled Generic Drugs Sales Market Share by Application (2019-2030)
5.2 Global Inhaled Generic Drugs Revenue by Application (2019-2030)
5.2.1 Global Inhaled Generic Drugs Revenue by Application (2019-2024)
5.2.2 Global Inhaled Generic Drugs Revenue by Application (2025-2030)
5.2.3 Global Inhaled Generic Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Inhaled Generic Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Inhaled Generic Drugs Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Inhaled Generic Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer-Ingelheim
6.3.1 Boehringer-Ingelheim Corporation Information
6.3.2 Boehringer-Ingelheim Description and Business Overview
6.3.3 Boehringer-Ingelheim Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer-Ingelheim Inhaled Generic Drugs Product Portfolio
6.3.5 Boehringer-Ingelheim Recent Developments/Updates
6.4 CTTQ
6.4.1 CTTQ Corporation Information
6.4.2 CTTQ Description and Business Overview
6.4.3 CTTQ Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CTTQ Inhaled Generic Drugs Product Portfolio
6.4.5 CTTQ Recent Developments/Updates
6.5 Sphsine
6.5.1 Sphsine Corporation Information
6.5.2 Sphsine Description and Business Overview
6.5.3 Sphsine Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sphsine Inhaled Generic Drugs Product Portfolio
6.5.5 Sphsine Recent Developments/Updates
6.6 Daphne Pharmaceutical
6.6.1 Daphne Pharmaceutical Corporation Information
6.6.2 Daphne Pharmaceutical Description and Business Overview
6.6.3 Daphne Pharmaceutical Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Daphne Pharmaceutical Inhaled Generic Drugs Product Portfolio
6.6.5 Daphne Pharmaceutical Recent Developments/Updates
6.7 Jewim Pharmaceutical
6.6.1 Jewim Pharmaceutical Corporation Information
6.6.2 Jewim Pharmaceutical Description and Business Overview
6.6.3 Jewim Pharmaceutical Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jewim Pharmaceutical Inhaled Generic Drugs Product Portfolio
6.7.5 Jewim Pharmaceutical Recent Developments/Updates
6.8 CF PharmTech
6.8.1 CF PharmTech Corporation Information
6.8.2 CF PharmTech Description and Business Overview
6.8.3 CF PharmTech Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CF PharmTech Inhaled Generic Drugs Product Portfolio
6.8.5 CF PharmTech Recent Developments/Updates
6.9 Xianju Pharmaceutical
6.9.1 Xianju Pharmaceutical Corporation Information
6.9.2 Xianju Pharmaceutical Description and Business Overview
6.9.3 Xianju Pharmaceutical Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Xianju Pharmaceutical Inhaled Generic Drugs Product Portfolio
6.9.5 Xianju Pharmaceutical Recent Developments/Updates
6.10 Joincare Pharmaceutical
6.10.1 Joincare Pharmaceutical Corporation Information
6.10.2 Joincare Pharmaceutical Description and Business Overview
6.10.3 Joincare Pharmaceutical Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Joincare Pharmaceutical Inhaled Generic Drugs Product Portfolio
6.10.5 Joincare Pharmaceutical Recent Developments/Updates
6.11 Hengrui Medicine
6.11.1 Hengrui Medicine Corporation Information
6.11.2 Hengrui Medicine Inhaled Generic Drugs Description and Business Overview
6.11.3 Hengrui Medicine Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hengrui Medicine Inhaled Generic Drugs Product Portfolio
6.11.5 Hengrui Medicine Recent Developments/Updates
6.12 Purity Pharmaceutical
6.12.1 Purity Pharmaceutical Corporation Information
6.12.2 Purity Pharmaceutical Inhaled Generic Drugs Description and Business Overview
6.12.3 Purity Pharmaceutical Inhaled Generic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Purity Pharmaceutical Inhaled Generic Drugs Product Portfolio
6.12.5 Purity Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhaled Generic Drugs Industry Chain Analysis
7.2 Inhaled Generic Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhaled Generic Drugs Production Mode & Process
7.4 Inhaled Generic Drugs Sales and Marketing
7.4.1 Inhaled Generic Drugs Sales Channels
7.4.2 Inhaled Generic Drugs Distributors
7.5 Inhaled Generic Drugs Customers
8 Inhaled Generic Drugs Market Dynamics
8.1 Inhaled Generic Drugs Industry Trends
8.2 Inhaled Generic Drugs Market Drivers
8.3 Inhaled Generic Drugs Market Challenges
8.4 Inhaled Generic Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Inhaled Generic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Inhaled Generic Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Inhaled Generic Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Inhaled Generic Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Inhaled Generic Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Inhaled Generic Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Inhaled Generic Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Inhaled Generic Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Inhaled Generic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inhaled Generic Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inhaled Generic Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Inhaled Generic Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhaled Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Generic Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhaled Generic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Inhaled Generic Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Inhaled Generic Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Inhaled Generic Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Inhaled Generic Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Inhaled Generic Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Inhaled Generic Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Inhaled Generic Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Inhaled Generic Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Inhaled Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Inhaled Generic Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Inhaled Generic Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Inhaled Generic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Inhaled Generic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Inhaled Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Inhaled Generic Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Inhaled Generic Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Inhaled Generic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Inhaled Generic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Inhaled Generic Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Inhaled Generic Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Inhaled Generic Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Inhaled Generic Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Inhaled Generic Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Inhaled Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Inhaled Generic Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Inhaled Generic Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Inhaled Generic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Inhaled Generic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Inhaled Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Inhaled Generic Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Inhaled Generic Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Inhaled Generic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Inhaled Generic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Inhaled Generic Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Inhaled Generic Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Inhaled Generic Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Inhaled Generic Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Inhaled Generic Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Inhaled Generic Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Inhaled Generic Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Inhaled Generic Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Inhaled Generic Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Inhaled Generic Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Inhaled Generic Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Inhaled Generic Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Inhaled Generic Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Inhaled Generic Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Inhaled Generic Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Inhaled Generic Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Inhaled Generic Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Inhaled Generic Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Inhaled Generic Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Inhaled Generic Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. GSK Inhaled Generic Drugs Product
Table 74. GSK Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. AstraZeneca Inhaled Generic Drugs Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Boehringer-Ingelheim Corporation Information
Table 81. Boehringer-Ingelheim Description and Business Overview
Table 82. Boehringer-Ingelheim Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer-Ingelheim Inhaled Generic Drugs Product
Table 84. Boehringer-Ingelheim Recent Developments/Updates
Table 85. CTTQ Corporation Information
Table 86. CTTQ Description and Business Overview
Table 87. CTTQ Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. CTTQ Inhaled Generic Drugs Product
Table 89. CTTQ Recent Developments/Updates
Table 90. Sphsine Corporation Information
Table 91. Sphsine Description and Business Overview
Table 92. Sphsine Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sphsine Inhaled Generic Drugs Product
Table 94. Sphsine Recent Developments/Updates
Table 95. Daphne Pharmaceutical Corporation Information
Table 96. Daphne Pharmaceutical Description and Business Overview
Table 97. Daphne Pharmaceutical Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Daphne Pharmaceutical Inhaled Generic Drugs Product
Table 99. Daphne Pharmaceutical Recent Developments/Updates
Table 100. Jewim Pharmaceutical Corporation Information
Table 101. Jewim Pharmaceutical Description and Business Overview
Table 102. Jewim Pharmaceutical Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Jewim Pharmaceutical Inhaled Generic Drugs Product
Table 104. Jewim Pharmaceutical Recent Developments/Updates
Table 105. CF PharmTech Corporation Information
Table 106. CF PharmTech Description and Business Overview
Table 107. CF PharmTech Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. CF PharmTech Inhaled Generic Drugs Product
Table 109. CF PharmTech Recent Developments/Updates
Table 110. Xianju Pharmaceutical Corporation Information
Table 111. Xianju Pharmaceutical Description and Business Overview
Table 112. Xianju Pharmaceutical Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Xianju Pharmaceutical Inhaled Generic Drugs Product
Table 114. Xianju Pharmaceutical Recent Developments/Updates
Table 115. Joincare Pharmaceutical Corporation Information
Table 116. Joincare Pharmaceutical Description and Business Overview
Table 117. Joincare Pharmaceutical Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Joincare Pharmaceutical Inhaled Generic Drugs Product
Table 119. Joincare Pharmaceutical Recent Developments/Updates
Table 120. Hengrui Medicine Corporation Information
Table 121. Hengrui Medicine Description and Business Overview
Table 122. Hengrui Medicine Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Hengrui Medicine Inhaled Generic Drugs Product
Table 124. Hengrui Medicine Recent Developments/Updates
Table 125. Purity Pharmaceutical Corporation Information
Table 126. Purity Pharmaceutical Description and Business Overview
Table 127. Purity Pharmaceutical Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Purity Pharmaceutical Inhaled Generic Drugs Product
Table 129. Purity Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Inhaled Generic Drugs Distributors List
Table 133. Inhaled Generic Drugs Customers List
Table 134. Inhaled Generic Drugs Market Trends
Table 135. Inhaled Generic Drugs Market Drivers
Table 136. Inhaled Generic Drugs Market Challenges
Table 137. Inhaled Generic Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inhaled Generic Drugs
Figure 2. Global Inhaled Generic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Inhaled Generic Drugs Market Share by Type in 2023 & 2030
Figure 4. DPI Product Picture
Figure 5. MDI Product Picture
Figure 6. NEB Product Picture
Figure 7. Global Inhaled Generic Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Inhaled Generic Drugs Market Share by Application in 2023 & 2030
Figure 9. Asthma
Figure 10. COPD
Figure 11. Inhalation Anesthesia
Figure 12. Others
Figure 13. Global Inhaled Generic Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Inhaled Generic Drugs Market Size (2019-2030) & (US$ Million)
Figure 15. Global Inhaled Generic Drugs Sales (2019-2030) & (K Units)
Figure 16. Global Inhaled Generic Drugs Average Price (US$/Unit) & (2019-2030)
Figure 17. Inhaled Generic Drugs Report Years Considered
Figure 18. Inhaled Generic Drugs Sales Share by Manufacturers in 2023
Figure 19. Global Inhaled Generic Drugs Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Inhaled Generic Drugs Players: Market Share by Revenue in 2023
Figure 21. Inhaled Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Inhaled Generic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Inhaled Generic Drugs Sales Market Share by Country (2019-2030)
Figure 24. North America Inhaled Generic Drugs Revenue Market Share by Country (2019-2030)
Figure 25. United States Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Inhaled Generic Drugs Sales Market Share by Country (2019-2030)
Figure 28. Europe Inhaled Generic Drugs Revenue Market Share by Country (2019-2030)
Figure 29. Germany Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Netherlands Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Inhaled Generic Drugs Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Inhaled Generic Drugs Revenue Market Share by Region (2019-2030)
Figure 36. China Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Inhaled Generic Drugs Sales Market Share by Country (2019-2030)
Figure 44. Latin America Inhaled Generic Drugs Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Inhaled Generic Drugs Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Inhaled Generic Drugs Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Inhaled Generic Drugs by Type (2019-2030)
Figure 55. Global Revenue Market Share of Inhaled Generic Drugs by Type (2019-2030)
Figure 56. Global Inhaled Generic Drugs Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Inhaled Generic Drugs by Application (2019-2030)
Figure 58. Global Revenue Market Share of Inhaled Generic Drugs by Application (2019-2030)
Figure 59. Global Inhaled Generic Drugs Price (US$/Unit) by Application (2019-2030)
Figure 60. Inhaled Generic Drugs Value Chain
Figure 61. Inhaled Generic Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
